@usob, there is no future for Ecte mainly due to Alan not taking any iniative trying to get funding to continue operations. The patents will most likely elapse.
Alan upon receiving hundreds of thousands of dollars in salaries and awarded more than 500,000 shares for doing nothing to bring life back to Ecte while he was appointed CEO.
At the very least he could have given the technology/prototype, lab tests and documentations to an independant lab to get a 3rd party opinion with a in depth report if Ectes technology would be feasable to have a working Non invasive CGM.
Alan has no business sense or was not willing to spend his own money which would possibly cost him anywhere from $25,000 to $50,000 being he had a bug stake in Ecte nor did he reach out to any shareholder for a loan to the company to get such a report. Secondly, when Alan was elected as Acting CEO Ecte had sufficient money to get such a report.
If the findings of Ecte technology from the independent lab was positive he would be able to easily get funding to continue operations on a limited scale to their completion of a workable prototype.
Bottom line Alan was just very happy collecting his fat salary as a glorified bookkeeper and when it came down to as being CEO he was way over his head and could not think out of the box of a plan as stated above to try to continue operations. All he wanted was to get his 500,000 shares and was hoping someone would bailout Ecte. Missed opportunity for the shareholders.
